Wealth Enhancement Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.7M Sell
8,478
-5,609
-40% -$1.91M 0.01% 1230
2025
Q4
$5.74M Sell
14,087
-438
-3% -$194K 0.01% 950
2025
Q3
$6.68M Buy
14,525
+9,407
+184% +$3.83M 0.01% 821
2025
Q2
$1.7M Sell
5,118
-9,286
-64% -$2.57M ﹤0.01% 1443
2025
Q1
$3.89M Buy
14,404
+1,838
+15% +$472K 0.01% 916
2024
Q4
$2.96M Buy
12,566
+6,112
+95% +$1.61M 0.01% 1003
2024
Q3
$1.77M Buy
6,454
+2,323
+56% +$605K ﹤0.01% 1117
2024
Q2
$1M Buy
4,131
+1,184
+40% +$187K ﹤0.01% 1275
2024
Q1
$440K Buy
2,947
+548
+23% +$91.4K ﹤0.01% 1658
2023
Q4
$459K Buy
2,399
+216
+10% +$36.8K ﹤0.01% 1558
2023
Q3
$387K Buy
+2,183
New +$416K ﹤0.01% 1588
2020
Q3
Sell
-8,758
Closed -$1.38M 206
2020
Q2
$1.38M Buy
+8,758
New +$1.18M 0.04% 159

Other funds holding ALNY